Evaluation of the effectiveness of a peptide-cytokine agent in the complex therapy of recurrent candidal vulvovaginitis

Background. The literature shows that up to 75% of women of reproductive age suffer at least one episode of acute candidal vulvovaginitis (CVV) in life, up to 45% report 2 cases or more, up to 20% experience recurrent (often complicated) course of this disease. Recurrent CVV requires a non-standard...

Full description

Saved in:
Bibliographic Details
Main Author: Elena A. Rosyuk
Format: Article
Language:Russian
Published: IP Berlin A.V. 2024-12-01
Series:Гинекология
Subjects:
Online Access:https://gynecology.orscience.ru/2079-5831/article/viewFile/643246/159193
Tags: Add Tag
No Tags, Be the first to tag this record!